These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38507608)

  • 41. Impact of a pharmacist-led medication review on hospital readmission in a pediatric and elderly population: study protocol for a randomized open-label controlled trial.
    Renaudin P; Baumstarck K; Daumas A; Esteve MA; Gayet S; Auquier P; Tsimaratos M; Villani P; Honore S
    Trials; 2017 Feb; 18(1):65. PubMed ID: 28183322
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study.
    Chang AR; Evans M; Yule C; Bohn L; Young A; Lewis M; Graboski E; Gerdy B; Ehmann W; Brady J; Lawrence L; Antunes N; Green J; Snyder S; Kirchner HL; Grams M; Perkins R
    BMC Nephrol; 2016 Nov; 17(1):168. PubMed ID: 27825313
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Handling drug-related problems in rehabilitation patients: a randomized study.
    Willoch K; Blix HS; Pedersen-Bjergaard AM; Eek AK; Reikvam A
    Int J Clin Pharm; 2012 Apr; 34(2):382-8. PubMed ID: 22388601
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of SENATOR (Software ENgine for the Assessment and optimisation of drug and non-drug Therapy in Older peRsons) on incident adverse drug reactions (ADRs) in an older hospital cohort - Trial Protocol.
    Lavan AH; O'Mahony D; Gallagher P; Fordham R; Flanagan E; Dahly D; Byrne S; Petrovic M; Gudmundsson A; Samuelsson O; Cherubini A; J Cruz-Jentoft A; Soiza RL; Eustace JA
    BMC Geriatr; 2019 Feb; 19(1):40. PubMed ID: 30760204
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of prescriber responses to pharmacist recommendations communicated by fax in a medication therapy management program (MTMP).
    Perera PN; Guy MC; Sweaney AM; Boesen KP
    J Manag Care Pharm; 2011 Jun; 17(5):345-54. PubMed ID: 21657804
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An inter-professional student-run medication review programme. Reducing adverse drug reactions in a memory outpatient clinic: a controlled clinical trial.
    Reumerman MO; Richir MC; Sultan R; Daelmans HEM; Springer H; Grijmans E; Muller M; van Agtmael MA; Tichelaar J
    Expert Opin Drug Saf; 2022 Dec; 21(12):1511-1520. PubMed ID: 35469517
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of continuous pharmaceutical care led by clinical pharmacists during transitions of care on medication adherence and clinical outcomes for patients with coronary heart disease: a prospective cohort study.
    Gao L; Han Y; Jia Z; Wang P; Zhang M; Ma T; Yan S; Liu H
    Front Pharmacol; 2023; 14():1249636. PubMed ID: 37693909
    [No Abstract]   [Full Text] [Related]  

  • 49. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
    Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
    Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transitioning patients with inflammatory bowel disease from hospital-based to rapid home-based infliximab: A stepwise, safety and patient-orientated process towards sustainability.
    Bohra A; Rizvi QA; Keung CYY; Vasudevan A; van Langenberg DR
    World J Gastroenterol; 2020 Sep; 26(36):5437-5449. PubMed ID: 33024395
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial.
    Murray MD; Young J; Hoke S; Tu W; Weiner M; Morrow D; Stroupe KT; Wu J; Clark D; Smith F; Gradus-Pizlo I; Weinberger M; Brater DC
    Ann Intern Med; 2007 May; 146(10):714-25. PubMed ID: 17502632
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interventions for fatigue in inflammatory bowel disease.
    Farrell D; Artom M; Czuber-Dochan W; Jelsness-Jørgensen LP; Norton C; Savage E
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD012005. PubMed ID: 32297974
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized controlled trial of a multicomponent online stress reduction intervention in inflammatory bowel disease.
    Peerani F; Watt M; Ismond KP; Whitlock R; Ambrosio L; Hotte N; Mitchell N; Bailey RJ; Kroeker K; Dieleman LA; Siffledeen J; Lim A; Wong K; Halloran BP; Baumgart DC; Taylor L; Raman M; Madsen KL; Tandon P
    Therap Adv Gastroenterol; 2022; 15():17562848221127238. PubMed ID: 36187365
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Medication review and patient counselling at discharge from the hospital by community pharmacists.
    Hugtenburg JG; Borgsteede SD; Beckeringh JJ
    Pharm World Sci; 2009 Dec; 31(6):630-7. PubMed ID: 19649720
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Medication reviews in the community: results of a randomized, controlled effectiveness trial.
    Sorensen L; Stokes JA; Purdie DM; Woodward M; Elliott R; Roberts MS
    Br J Clin Pharmacol; 2004 Dec; 58(6):648-64. PubMed ID: 15563363
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intervention of pharmacist included in multidisciplinary team to reduce adverse drug event: a qualitative systematic review.
    Zaij S; Pereira Maia K; Leguelinel-Blache G; Roux-Marson C; Kinowski JM; Richard H
    BMC Health Serv Res; 2023 Aug; 23(1):927. PubMed ID: 37649018
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
    Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
    J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Paradoxical articular manifestations in patients with inflammatory bowel diseases treated with infliximab.
    Thiebault H; Boyard-Lasselin P; Guignant C; Guillaume N; Wacrenier A; Sabbagh C; Rebibo L; Brazier F; Meynier J; Nguyen-Khac E; Dupas JL; Goëb V; Fumery M
    Eur J Gastroenterol Hepatol; 2016 Aug; 28(8):876-81. PubMed ID: 27101404
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Providing patients with information about disease-modifying anti-rheumatic drugs: Individually or in groups? A pilot randomized controlled trial comparing adherence and satisfaction.
    Homer D; Nightingale P; Jobanputra P
    Musculoskeletal Care; 2009 Jun; 7(2):78-92. PubMed ID: 18792423
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.